Quick Search (by title or disease)

Go to Advanced Search for more options.

Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

  Sip Protocol

Masonic Cancer Research Center
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Back to Search Instructions

Protocol No. 2013CG015 Principal Investigator Greengard, Emily
Phase Phase I/II
Age Group Both Scope National
Secondary Protocol No. AHOD1221
Title COG AHOD1221: A Phase 1/2 Study of Brentuximab Vedotin (SGN35, IND# 117117) in Combination with Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma
Applicable Disease Sites Hodgkin's Lymphoma
Drugs Involved Brentuximab vendotin (ADCETRIS)
Status Open
Participating Institutions Masonic Cancer Center
St. Mary's Duluth Clinic
Treatment Type Treatment
Contact Cancer Information Line nurse Phone: 612-624-2620 - 1-888-226-2376
Email: ccinfo@umn.edu